North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Size and Forecast (2021 - 2031)
The North America Noninvasive Traumatic Brain Injury (TBI) Diagnostic Equipment Market is projected to grow significantly, reaching approximately US$ 1,648.8 million by 2031, up from US$ 724.9 million in 2024. This growth represents a compound annual growth rate (CAGR) of 12.5% from 2025 to 2031.
Executive Summary and Market Analysis
The rising incidence of TBI is creating a considerable economic impact, necessitating the development of innovative noninvasive diagnostic methods. Techniques such as near-infrared spectroscopy (NIRS), transcranial Doppler (TCD) ultrasound, and advanced imaging technologies have transformed TBI assessment, providing safer, faster, and more cost-effective alternatives to traditional imaging methods like CT scans. These innovations allow healthcare professionals to detect and monitor brain injuries more effectively, leading to improved patient outcomes.
There is an increasing demand for portable and point-of-care diagnostic solutions. Devices like BrainScope One exemplify this trend, offering rapid, noninvasive assessments that can be utilized in emergency situations, thereby minimizing the reliance on expensive and time-consuming imaging procedures. This is particularly advantageous in areas with limited access to advanced imaging technologies.
The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic tools is enhancing the accuracy and efficiency of TBI detection. For instance, the development of interpretable 3D multi-modal residual convolutional neural networks (MRCNN) has shown promising results in diagnosing mild TBI, providing improved specificity and accuracy compared to traditional CT-based models. These AI-driven methodologies facilitate quicker and more precise diagnoses, which are crucial for timely intervention and management of TBI patients.
Support from the US government through funding and regulatory frameworks is accelerating the adoption of noninvasive diagnostic technologies. Initiatives aimed at improving trauma care and expanding access to advanced diagnostics are being implemented. Furthermore, the competitive landscape among medical device companies in North America fosters innovation in TBI diagnostic equipment. The region's advanced healthcare infrastructure, high prevalence of TBI, and commitment to research and development contribute to its leadership in the noninvasive TBI diagnostic equipment market.
Strategic Insights
Market Segmentation Analysis
The North America Noninvasive TBI Diagnostic Equipment Market is segmented by various techniques, including:
Additionally, the market is segmented by non-invasive ICP methods, including TCD, Tympanic Membrane Displacement (TMD), Optic Nerve Sheath Diameter (ONSD), MRI, CT, and others, with MRI and CT leading in 2024. The market is also divided by device type into imaging devices and monitoring devices, with imaging devices holding the largest share in 2024. By end user, hospitals and clinics dominated the market.
Market Outlook
The integration of multimodal and hybrid diagnostic platforms is addressing the limitations of single-modality approaches, which often fail to capture the complexity of TBI. By combining various noninvasive techniques, these platforms provide a more comprehensive assessment, enhancing diagnosis, prognosis, and treatment planning.
Recent developments emphasize the creation of seamless, data-driven diagnostic systems. While imaging techniques like CT and MRI are vital for identifying structural damage, they may overlook subtle neuronal injuries common in mild TBI. Blood biomarkers such as Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) offer rapid, objective measures of cellular injury that may not be visible on scans. Integrated platforms are being developed to utilize both imaging and biomarker data, potentially involving a portable blood test that, if positive, triggers an AI-enhanced neuroimaging scan for detailed analysis.
Country Insights
The North American market is primarily segmented into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. An estimated 1.7 million individuals sustain mild TBI annually in the US, highlighting the urgent need for effective diagnostic tools. EEG-based platforms, such as those from BrainScope Company, Inc., are emerging as rapid, noninvasive alternatives to traditional methods. The US market's growth is driven by its advanced healthcare infrastructure, high TBI prevalence, and a strong commitment to research and development.
Company Profiles
Key players in the North America Noninvasive TBI Diagnostic Equipment Market include Integra LifeSciences Holdings Corp, Medtronic Plc, Koninklijke Philips NV, GE HealthCare Technologies Inc, Natus Medical Inc, Nihon Kohden Corp, Elekta AB, BrainScope Co Inc, Siemens Healthineers AG, and Luciole Medical AG. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence.
documents, alongside primary research through interviews with industry stakeholders to validate findings and gain insights into market dynamics.
Executive Summary and Market Analysis
The rising incidence of TBI is creating a considerable economic impact, necessitating the development of innovative noninvasive diagnostic methods. Techniques such as near-infrared spectroscopy (NIRS), transcranial Doppler (TCD) ultrasound, and advanced imaging technologies have transformed TBI assessment, providing safer, faster, and more cost-effective alternatives to traditional imaging methods like CT scans. These innovations allow healthcare professionals to detect and monitor brain injuries more effectively, leading to improved patient outcomes.
There is an increasing demand for portable and point-of-care diagnostic solutions. Devices like BrainScope One exemplify this trend, offering rapid, noninvasive assessments that can be utilized in emergency situations, thereby minimizing the reliance on expensive and time-consuming imaging procedures. This is particularly advantageous in areas with limited access to advanced imaging technologies.
The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic tools is enhancing the accuracy and efficiency of TBI detection. For instance, the development of interpretable 3D multi-modal residual convolutional neural networks (MRCNN) has shown promising results in diagnosing mild TBI, providing improved specificity and accuracy compared to traditional CT-based models. These AI-driven methodologies facilitate quicker and more precise diagnoses, which are crucial for timely intervention and management of TBI patients.
Support from the US government through funding and regulatory frameworks is accelerating the adoption of noninvasive diagnostic technologies. Initiatives aimed at improving trauma care and expanding access to advanced diagnostics are being implemented. Furthermore, the competitive landscape among medical device companies in North America fosters innovation in TBI diagnostic equipment. The region's advanced healthcare infrastructure, high prevalence of TBI, and commitment to research and development contribute to its leadership in the noninvasive TBI diagnostic equipment market.
Strategic Insights
Market Segmentation Analysis
The North America Noninvasive TBI Diagnostic Equipment Market is segmented by various techniques, including:
- Electroencephalography (EEG)
- Brain-computer interface (BCI)
- Eye tracking and near-infrared spectroscopy (NIRS)
- Magnetic resonance imaging (MRI)
- Magnetoencephalography (MEG)
- Transcranial magnetic stimulation (TMS)
- Cerebral metabolic rate of oxygen (CMRO2)
- Intracranial Pressure
- Others
Additionally, the market is segmented by non-invasive ICP methods, including TCD, Tympanic Membrane Displacement (TMD), Optic Nerve Sheath Diameter (ONSD), MRI, CT, and others, with MRI and CT leading in 2024. The market is also divided by device type into imaging devices and monitoring devices, with imaging devices holding the largest share in 2024. By end user, hospitals and clinics dominated the market.
Market Outlook
The integration of multimodal and hybrid diagnostic platforms is addressing the limitations of single-modality approaches, which often fail to capture the complexity of TBI. By combining various noninvasive techniques, these platforms provide a more comprehensive assessment, enhancing diagnosis, prognosis, and treatment planning.
Recent developments emphasize the creation of seamless, data-driven diagnostic systems. While imaging techniques like CT and MRI are vital for identifying structural damage, they may overlook subtle neuronal injuries common in mild TBI. Blood biomarkers such as Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) offer rapid, objective measures of cellular injury that may not be visible on scans. Integrated platforms are being developed to utilize both imaging and biomarker data, potentially involving a portable blood test that, if positive, triggers an AI-enhanced neuroimaging scan for detailed analysis.
Country Insights
The North American market is primarily segmented into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. An estimated 1.7 million individuals sustain mild TBI annually in the US, highlighting the urgent need for effective diagnostic tools. EEG-based platforms, such as those from BrainScope Company, Inc., are emerging as rapid, noninvasive alternatives to traditional methods. The US market's growth is driven by its advanced healthcare infrastructure, high TBI prevalence, and a strong commitment to research and development.
Company Profiles
Key players in the North America Noninvasive TBI Diagnostic Equipment Market include Integra LifeSciences Holdings Corp, Medtronic Plc, Koninklijke Philips NV, GE HealthCare Technologies Inc, Natus Medical Inc, Nihon Kohden Corp, Elekta AB, BrainScope Co Inc, Siemens Healthineers AG, and Luciole Medical AG. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence.
documents, alongside primary research through interviews with industry stakeholders to validate findings and gain insights into market dynamics.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue (US$ Million), 2024 - 2031
6.2 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Forecast and Analysis
7. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY TECHNIQUES
7.1 Electroencephalography (EEG)
7.1.1 Overview
7.1.2 Electroencephalography (EEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Brain-computer interface (BCI)
7.2.1 Overview
7.2.2 Brain-computer interface (BCI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Eye tracking and near-infrared spectroscopy (NIRS)
7.3.1 Overview
7.3.2 Eye tracking and near-infrared spectroscopy (NIRS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Magnetic resonance imaging (MRI)
7.4.1 Overview
7.4.2 Magnetic resonance imaging (MRI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Magnetoencephalography (MEG)
7.5.1 Overview
7.5.2 Magnetoencephalography (MEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Transcranial magnetic stimulation (TMS)
7.6.1 Overview
7.6.2 Transcranial magnetic stimulation (TMS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cerebral metabolic rate of oxygen (CMRO2)
7.7.1 Overview
7.7.2 Cerebral metabolic rate of oxygen (CMRO2): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Intracranial Pressure
7.8.1 Overview
7.8.2 Intracranial Pressure: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY NON-INVASIVE ICP
8.1 Transcranial Doppler Ultrasonography (TCD)
8.1.1 Overview
8.1.2 Transcranial Doppler Ultrasonography (TCD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Tympanic Membrane Displacement (TMD)
8.2.1 Overview
8.2.2 Tympanic Membrane Displacement (TMD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Optic Nerve Sheath Diameter (ONSD)
8.3.1 Overview
8.3.2 Optic Nerve Sheath Diameter (ONSD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT)
8.4.1 Overview
8.4.2 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Fundoscopy and Papilledema
8.5.1 Overview
8.5.2 Fundoscopy and Papilledema: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY DEVICE
9.1 Imaging devices
9.1.1 Overview
9.1.2 Imaging devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Monitoring Devices
9.2.1 Overview
9.2.2 Monitoring Devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY END USER
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Diagnostic Centers
10.2.1 Overview
10.2.2 Diagnostic Centers: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - COUNTRY ANALYSIS
11.1 North America
11.1.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue and Forecast and Analysis - by Country
11.1.1.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue and Forecast and Analysis - by Country
11.1.2.2 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.1.2.2.2 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.1.2.2.3 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.1.2.2.4 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
11.2.3.3 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.2.3.3.2 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.2.3.3.3 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.2.3.3.4 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
11.3.4.4 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.3.4.4.2 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.3.4.4.3 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.3.4.4.4 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Integra LifeSciences Holdings Corp
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Medtronic Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Koninklijke Philips NV
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GE HealthCare Technologies Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Natus Medical Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Nihon Kohden Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Elekta AB
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 BrainScope Co Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens Healthineers AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Luciole Medical AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue (US$ Million), 2024 - 2031
6.2 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Forecast and Analysis
7. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY TECHNIQUES
7.1 Electroencephalography (EEG)
7.1.1 Overview
7.1.2 Electroencephalography (EEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Brain-computer interface (BCI)
7.2.1 Overview
7.2.2 Brain-computer interface (BCI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Eye tracking and near-infrared spectroscopy (NIRS)
7.3.1 Overview
7.3.2 Eye tracking and near-infrared spectroscopy (NIRS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Magnetic resonance imaging (MRI)
7.4.1 Overview
7.4.2 Magnetic resonance imaging (MRI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Magnetoencephalography (MEG)
7.5.1 Overview
7.5.2 Magnetoencephalography (MEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Transcranial magnetic stimulation (TMS)
7.6.1 Overview
7.6.2 Transcranial magnetic stimulation (TMS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cerebral metabolic rate of oxygen (CMRO2)
7.7.1 Overview
7.7.2 Cerebral metabolic rate of oxygen (CMRO2): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Intracranial Pressure
7.8.1 Overview
7.8.2 Intracranial Pressure: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY NON-INVASIVE ICP
8.1 Transcranial Doppler Ultrasonography (TCD)
8.1.1 Overview
8.1.2 Transcranial Doppler Ultrasonography (TCD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Tympanic Membrane Displacement (TMD)
8.2.1 Overview
8.2.2 Tympanic Membrane Displacement (TMD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Optic Nerve Sheath Diameter (ONSD)
8.3.1 Overview
8.3.2 Optic Nerve Sheath Diameter (ONSD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT)
8.4.1 Overview
8.4.2 Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Fundoscopy and Papilledema
8.5.1 Overview
8.5.2 Fundoscopy and Papilledema: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY DEVICE
9.1 Imaging devices
9.1.1 Overview
9.1.2 Imaging devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Monitoring Devices
9.2.1 Overview
9.2.2 Monitoring Devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET REVENUE ANALYSIS - BY END USER
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Diagnostic Centers
10.2.1 Overview
10.2.2 Diagnostic Centers: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA NONINVASIVE TRAUMATIC BRAIN INJURY DIAGNOSTIC EQUIPMENT MARKET - COUNTRY ANALYSIS
11.1 North America
11.1.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue and Forecast and Analysis - by Country
11.1.1.1 North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue and Forecast and Analysis - by Country
11.1.2.2 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.1.2.2.2 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.1.2.2.3 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.1.2.2.4 United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
11.2.3.3 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.2.3.3.2 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.2.3.3.3 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.2.3.3.4 Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
11.3.4.4 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Techniques
11.3.4.4.2 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Non-invasive Icp
11.3.4.4.3 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by Device
11.3.4.4.4 Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Integra LifeSciences Holdings Corp
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Medtronic Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Koninklijke Philips NV
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GE HealthCare Technologies Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Natus Medical Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Nihon Kohden Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Elekta AB
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 BrainScope Co Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens Healthineers AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Luciole Medical AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Segmentation
Table 3. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 5. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 6. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 7. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 10. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 11. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 12. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 14. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 15. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 16. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 18. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 19. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 20. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Heat Map Analysis by Key Players
Table 1. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Segmentation
Table 3. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 5. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 6. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 7. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 10. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 11. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 12. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 14. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 15. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 16. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Techniques
Table 18. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Non-invasive Icp
Table 19. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device
Table 20. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Techniques, 2024 and 2031
Figure 8. Electroencephalography (EEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Brain-computer interface (BCI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Eye tracking and near-infrared spectroscopy (NIRS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Magnetic resonance imaging (MRI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Magnetoencephalography (MEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Transcranial magnetic stimulation (TMS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cerebral metabolic rate of oxygen (CMRO2): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Intracranial Pressure: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Non-invasive Icp, 2024 and 2031
Figure 18. Transcranial Doppler Ultrasonography (TCD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Tympanic Membrane Displacement (TMD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Optic Nerve Sheath Diameter (ONSD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Fundoscopy and Papilledema: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Device, 2024 and 2031
Figure 24. Imaging devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Monitoring Devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by End User, 2024 and 2031
Figure 27. Hospitals and Clinics: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Diagnostic Centers: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Company Positioning & Concentration
Figure 1. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Techniques, 2024 and 2031
Figure 8. Electroencephalography (EEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Brain-computer interface (BCI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Eye tracking and near-infrared spectroscopy (NIRS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Magnetic resonance imaging (MRI): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Magnetoencephalography (MEG): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Transcranial magnetic stimulation (TMS): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cerebral metabolic rate of oxygen (CMRO2): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Intracranial Pressure: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Non-invasive Icp, 2024 and 2031
Figure 18. Transcranial Doppler Ultrasonography (TCD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Tympanic Membrane Displacement (TMD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Optic Nerve Sheath Diameter (ONSD): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Magnetic Resonance Imaging (MRI) and Computer Tomography (CT): North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Fundoscopy and Papilledema: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by Device, 2024 and 2031
Figure 24. Imaging devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Monitoring Devices: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share (%) - by End User, 2024 and 2031
Figure 27. Hospitals and Clinics: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Diagnostic Centers: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Others: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. United States: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Canada: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Mexico: North America Noninvasive Traumatic Brain Injury Diagnostic Equipment Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Company Positioning & Concentration
